首页 > 最新文献

Enfermedades infecciosas y microbiologia clinica最新文献

英文 中文
Unsuccessful tuberculosis-treatment in HIV-positive patients and associated factors hiv阳性患者结核病治疗失败及其相关因素
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.06.008
Guillermo Bosch , Joan-Pau Millet , Àngels Orcau , Isabel Moreira , Carles Pericas , Lluïsa Forns , Isabel Marcos , Raquel Prieto , Anna Hernandez , Lídia Arranz , Cristina Rius

Background

TB is one of the most deathly infections worldwide, affecting disproportionally people living with HIV (PLHIV). Furthermore, HIV co-infection is related to worse outcomes for TB patients, including lower treatment success.

Methods

Using surveillance records of all TB cases notified in Barcelona city from 2001 to 2021, we analyzed TB treatment success according to HIV status. Additionally, we explored potential social and health related and factors associated to unsuccessful treatment in PLHIV, using multiple regression analyses.

Results

Out of the 8406 new TB cases diagnosed during the study period, 9% were co-infected with HIV. According to our regression models, PLHIV were more frequently men, users of injected drugs (aOR = 45.81; 95% CI (33.10–64.26)), had previously been treated for TB (aOR = 1.77; 95% CI (1.30–2.40)) and had a lower rate of contact tracing (aOR = 0.51; 95% CI (0.40–0.64)). Among PLHIV, unsuccessful treatment was related to the use of injected drugs and homelessness, but it was lower for those who had undergone contact tracing.

Conclusion

PLHIV have higher odds of unsuccessful TB treatment, especially those who are homeless and use injected drugs. Contact tracing improved treatment success, calling for further efforts and resources to correctly follow-up on these patients, with the goal of increasing treatment success.
结核病是全世界最致命的传染病之一,对艾滋病毒感染者(PLHIV)的影响不成比例。此外,艾滋病毒合并感染与结核病患者预后较差有关,包括治疗成功率较低。方法利用巴塞罗那市2001 - 2021年报告的所有结核病例监测记录,根据HIV感染情况分析结核治疗成功情况。此外,我们利用多元回归分析探讨了与hiv治疗失败相关的潜在社会和健康因素。结果在研究期间诊断的8406例新结核病例中,9%合并感染艾滋病毒。根据我们的回归模型,PLHIV感染者多为男性,注射药物使用者(aOR = 45.81; 95% CI(33.10-64.26)),以前接受过结核病治疗(aOR = 1.77; 95% CI(1.30-2.40)),接触者追踪率较低(aOR = 0.51; 95% CI(0.40-0.64))。在艾滋病毒感染者中,治疗失败与注射毒品的使用和无家可归有关,但与那些接受过接触者追踪的人有关。结论艾滋病毒感染者结核病治疗失败的几率较高,尤其是无家可归者和注射吸毒者。接触者追踪提高了治疗成功率,要求进一步努力和投入资源,对这些患者进行正确的随访,目标是提高治疗成功率。
{"title":"Unsuccessful tuberculosis-treatment in HIV-positive patients and associated factors","authors":"Guillermo Bosch ,&nbsp;Joan-Pau Millet ,&nbsp;Àngels Orcau ,&nbsp;Isabel Moreira ,&nbsp;Carles Pericas ,&nbsp;Lluïsa Forns ,&nbsp;Isabel Marcos ,&nbsp;Raquel Prieto ,&nbsp;Anna Hernandez ,&nbsp;Lídia Arranz ,&nbsp;Cristina Rius","doi":"10.1016/j.eimc.2025.06.008","DOIUrl":"10.1016/j.eimc.2025.06.008","url":null,"abstract":"<div><h3>Background</h3><div>TB is one of the most deathly infections worldwide, affecting disproportionally people living with HIV (PLHIV). Furthermore, HIV co-infection is related to worse outcomes for TB patients, including lower treatment success.</div></div><div><h3>Methods</h3><div>Using surveillance records of all TB cases notified in Barcelona city from 2001 to 2021, we analyzed TB treatment success according to HIV status. Additionally, we explored potential social and health related and factors associated to unsuccessful treatment in PLHIV, using multiple regression analyses.</div></div><div><h3>Results</h3><div>Out of the 8406 new TB cases diagnosed during the study period, 9% were co-infected with HIV. According to our regression models, PLHIV were more frequently men, users of injected drugs (aOR<!--> <!-->=<!--> <!-->45.81; 95% CI (33.10–64.26)), had previously been treated for TB (aOR<!--> <!-->=<!--> <!-->1.77; 95% CI (1.30–2.40)) and had a lower rate of contact tracing (aOR<!--> <!-->=<!--> <!-->0.51; 95% CI (0.40–0.64)). Among PLHIV, unsuccessful treatment was related to the use of injected drugs and homelessness, but it was lower for those who had undergone contact tracing.</div></div><div><h3>Conclusion</h3><div>PLHIV have higher odds of unsuccessful TB treatment, especially those who are homeless and use injected drugs. Contact tracing improved treatment success, calling for further efforts and resources to correctly follow-up on these patients, with the goal of increasing treatment success.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 666-673"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sobre «Análisis comparativo de las infecciones respiratorias agudas de etiología viral en menores de 6 meses con y sin nirsevimab en Baleares (2022-2023 y 2023-2024)» 关于“巴利阿里群岛(2022-2023年和2023-2024年)使用和不使用nirsevimab的6个月以下儿童急性病毒性呼吸道感染的比较分析”
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.06.020
Paula Corihuela Menéndez, Sacramento M. Segovia López, Alejandra Méndez Sánchez, Lara González García
{"title":"Sobre «Análisis comparativo de las infecciones respiratorias agudas de etiología viral en menores de 6 meses con y sin nirsevimab en Baleares (2022-2023 y 2023-2024)»","authors":"Paula Corihuela Menéndez,&nbsp;Sacramento M. Segovia López,&nbsp;Alejandra Méndez Sánchez,&nbsp;Lara González García","doi":"10.1016/j.eimc.2025.06.020","DOIUrl":"10.1016/j.eimc.2025.06.020","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 723-724"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifocal hydatidosis with osteoarticular, gynecological and hepatic involvement 多灶性包虫病伴骨关节、妇科和肝脏受累
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.05.002
Loreto Sangorrin-Lapieza , Pilar Hernández-Jiménez , Cristina Ojeda-Thies , Ana Pérez-Ayala
{"title":"Multifocal hydatidosis with osteoarticular, gynecological and hepatic involvement","authors":"Loreto Sangorrin-Lapieza ,&nbsp;Pilar Hernández-Jiménez ,&nbsp;Cristina Ojeda-Thies ,&nbsp;Ana Pérez-Ayala","doi":"10.1016/j.eimc.2025.05.002","DOIUrl":"10.1016/j.eimc.2025.05.002","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 709-710"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research on the relationship between HPV infection and alterations in vaginal microbial ecology HPV感染与阴道微生物生态改变关系的研究
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.07.008
Min Guo , Chaoyang Chen , Wenling Wang , Cairong Zhang , Jie Ma , Maidinamu Sadike , Mayinuer Niyazi , Xiaoli Feng , Kaichun Zhu

Objective

To investigate the changes in vaginal microbiota under different HPV infection statuses and explore the correlation between vaginal microbiota alterations and HPV infection.

Methods

151 cervical samples from gynecological outpatients were grouped into HPV-negative (HN, N = 51), transient infection (HTI, N = 42), and persistent infection (HPI, N = 58). Vaginal secretions were collected to assess microecology (pH, vaginal cleanliness, hydrogen peroxide, leukocyte esterase) via genital secretion analyzer. 16S ribosomal RNA (rRNA) sequencing analyzed vaginal microbiota characteristics, community state types (CST), richness, diversity, and biomarkers.

Results

16S rRNA sequencing identified 5 CST II, 52 CST III, and 94 mixed CST IV samples, showing diverse microbiota. Compared with HN, HTI and HPI had lower vaginal cleanliness, higher sialidase activity, elevated pH, and fewer Lactobacilli (P < 0.05). Lactobacillus iners dominated all groups, while Sneathia amnii was significantly higher in HPI (P < 0.05). HPV infection increased vaginal microbiota richness (HPI > HTI/HN, P < 0.05), with distinct group compositions (P < 0.05). Linear Discriminant Analysis Effect Size identified Lactobacillus gasseri, Atopobium vaginae, and Lactobacillus jensenii as biomarkers.

Conclusion

This study found significant differences in microbial community characteristics under different HPV infection statuses. The identification of biomarkers in vaginal microbiota under different infection statuses could provide new targets for clinical screening and prevention of cervical cancer.
目的观察不同HPV感染状态下阴道菌群的变化,探讨阴道菌群变化与HPV感染的相关性。方法将151例妇科门诊患者宫颈标本分为hpv阴性(HN, N = 51)、短暂性感染(HTI, N = 42)和持续性感染(HPI, N = 58)。收集阴道分泌物,通过阴道分泌物分析仪评估微生态(pH、阴道清洁度、过氧化氢、白细胞酯酶)。16S核糖体RNA (rRNA)测序分析阴道微生物群特征、群落状态类型(CST)、丰富度、多样性和生物标志物。结果16s rRNA测序鉴定出5份CST II、52份CST III和94份混合CST IV样品,显示出不同的微生物群。与HN相比,HTI和HPI阴道清洁度较低,唾液酸酶活性较高,pH升高,乳酸菌较少(P < 0.05)。各组均以嗜乳杆菌为主,羊水Sneathia HPI显著高于对照组(P < 0.05)。HPV感染增加了阴道菌群丰富度(HPI > HTI/HN, P < 0.05),但组间组成差异显著(P < 0.05)。线性判别分析效应大小鉴定出气体乳杆菌、阴道托泊菌和延seni乳杆菌作为生物标志物。结论不同HPV感染状态下微生物群落特征存在显著差异。不同感染状态下阴道菌群生物标志物的鉴定可为宫颈癌的临床筛查和预防提供新的靶点。
{"title":"Research on the relationship between HPV infection and alterations in vaginal microbial ecology","authors":"Min Guo ,&nbsp;Chaoyang Chen ,&nbsp;Wenling Wang ,&nbsp;Cairong Zhang ,&nbsp;Jie Ma ,&nbsp;Maidinamu Sadike ,&nbsp;Mayinuer Niyazi ,&nbsp;Xiaoli Feng ,&nbsp;Kaichun Zhu","doi":"10.1016/j.eimc.2025.07.008","DOIUrl":"10.1016/j.eimc.2025.07.008","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the changes in vaginal microbiota under different HPV infection statuses and explore the correlation between vaginal microbiota alterations and HPV infection.</div></div><div><h3>Methods</h3><div>151 cervical samples from gynecological outpatients were grouped into HPV-negative (HN, <em>N</em> <!-->=<!--> <!-->51), transient infection (HTI, <em>N</em> <!-->=<!--> <!-->42), and persistent infection (HPI, <em>N</em> <!-->=<!--> <!-->58). Vaginal secretions were collected to assess microecology (pH, vaginal cleanliness, hydrogen peroxide, leukocyte esterase) via genital secretion analyzer. 16S ribosomal RNA (rRNA) sequencing analyzed vaginal microbiota characteristics, community state types (CST), richness, diversity, and biomarkers.</div></div><div><h3>Results</h3><div>16S rRNA sequencing identified 5 CST II, 52 CST III, and 94 mixed CST IV samples, showing diverse microbiota. Compared with HN, HTI and HPI had lower vaginal cleanliness, higher sialidase activity, elevated pH, and fewer <em>Lactobacilli</em> (<em>P</em> <!-->&lt;<!--> <!-->0.05). <em>Lactobacillus iners</em> dominated all groups, while <em>Sneathia amnii</em> was significantly higher in HPI (<em>P</em> <!-->&lt;<!--> <!-->0.05). HPV infection increased vaginal microbiota richness (HPI<!--> <!-->&gt;<!--> <!-->HTI/HN, <em>P</em> <!-->&lt;<!--> <!-->0.05), with distinct group compositions (<em>P</em> <!-->&lt;<!--> <!-->0.05). Linear Discriminant Analysis Effect Size identified <em>Lactobacillus gasseri</em>, <em>Atopobium vaginae</em>, and <em>Lactobacillus jensenii</em> as biomarkers.</div></div><div><h3>Conclusion</h3><div>This study found significant differences in microbial community characteristics under different HPV infection statuses. The identification of biomarkers in vaginal microbiota under different infection statuses could provide new targets for clinical screening and prevention of cervical cancer.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 688-697"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infección de prótesis mamaria por Burkholderia cenocepacia 新发伯克霍尔德氏菌乳腺假体感染
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.07.004
María Alonso Girón , Laura Sante Fernández , Eulalia Vives Rodríguez , José Andrés Agulla Budiño
{"title":"Infección de prótesis mamaria por Burkholderia cenocepacia","authors":"María Alonso Girón ,&nbsp;Laura Sante Fernández ,&nbsp;Eulalia Vives Rodríguez ,&nbsp;José Andrés Agulla Budiño","doi":"10.1016/j.eimc.2025.07.004","DOIUrl":"10.1016/j.eimc.2025.07.004","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 719-721"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis 西班牙初级保健中的低努力艾滋病毒培训:对检测和诊断的长期影响
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.06.016
Alejandro G. García-Ruiz de Morales , María Jesús Vivancos , Beatriz Romero-Hernández , David Rial-Crestelo , Francisco Arnaiz de las Revillas , Jorge Sanchez-Villegas , Marta Montero Alonso , María de la Villa López Sánchez , María Remedios Alemán Valls , Santiago Moreno , Javier Martínez-Sanz , María Jesús Pérez-Elías , on behalf of CoRIS

Background

Recent improvements in the HIV care cascade have reduced HIV incidence in high- and middle-income countries, yet late HIV diagnosis remains a critical issue. This study examines the impact of a two-hour training session on HIV testing and diagnosis rates in primary care centers in Madrid, Spain.

Methods

In 2017, we conducted a non-mandatory, two-hour training session on updated HIV and HCV guidelines for primary care providers in 20 centers within the Ramón y Cajal Hospital area. We compared yearly HIV testing rates and late diagnosis rates in the five years before and after the intervention. We used data from Ramón y Cajal Hospital Microbiology Department's electronic records and the CoRIS cohort, including demographic and clinical information.

Results

Of the 630 target primary care providers, 454 (72%) attended the sessions. HIV testing rates increased from 1780 to 2155 tests per 100,000 inhabitants (p < 0.0001) post-intervention, with a stable rate of positive tests. Late diagnosis rates in our area decreased from 58.9% to 48.7%, while rates in the rest of Madrid and Spain increased (AOR 1.22, p < 0.001). The intervention area showed a significant reduction in advanced HIV disease (AOR 0.66, p = 0.095), contrasting with the upward trend in other regions.

Conclusion

A simple two-hour training session for primary care providers effectively increased HIV testing rates and reduced late diagnoses in our health area compared to national trends. Implementing similar strategies on a broader scale could help mitigate the rising rates of late HIV diagnosis and improve overall community health outcomes.
最近艾滋病毒护理级联的改进降低了高收入和中等收入国家的艾滋病毒发病率,但艾滋病毒的晚期诊断仍然是一个关键问题。本研究考察了西班牙马德里初级保健中心的两个小时培训课程对艾滋病毒检测和诊断率的影响。方法2017年,我们在Ramón y Cajal医院地区的20个中心对初级保健提供者进行了为期两小时的非强制性培训,内容是最新的HIV和HCV指南。我们比较了干预前后五年的年度HIV检测率和晚期诊断率。我们使用的数据来自Ramón y Cajal医院微生物科的电子记录和CoRIS队列,包括人口统计和临床信息。结果630名目标初级保健提供者中,454名(72%)参加了会议。干预后,艾滋病毒检测率从每10万居民1780例增加到2155例(p < 0.0001),阳性检测率保持稳定。我们地区的晚期诊断率从58.9%下降到48.7%,而马德里和西班牙其他地区的晚期诊断率上升(AOR为1.22,p < 0.001)。干预区HIV晚期发病率显著降低(AOR为0.66,p = 0.095),而其他地区呈上升趋势。结论与全国趋势相比,对初级保健提供者进行简单的两小时培训可有效提高本卫生区域的艾滋病毒检测率,减少晚期诊断。在更广泛的范围内实施类似的战略可以帮助减缓艾滋病毒晚期诊断率的上升,并改善总体社区卫生结果。
{"title":"Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis","authors":"Alejandro G. García-Ruiz de Morales ,&nbsp;María Jesús Vivancos ,&nbsp;Beatriz Romero-Hernández ,&nbsp;David Rial-Crestelo ,&nbsp;Francisco Arnaiz de las Revillas ,&nbsp;Jorge Sanchez-Villegas ,&nbsp;Marta Montero Alonso ,&nbsp;María de la Villa López Sánchez ,&nbsp;María Remedios Alemán Valls ,&nbsp;Santiago Moreno ,&nbsp;Javier Martínez-Sanz ,&nbsp;María Jesús Pérez-Elías ,&nbsp;on behalf of CoRIS","doi":"10.1016/j.eimc.2025.06.016","DOIUrl":"10.1016/j.eimc.2025.06.016","url":null,"abstract":"<div><h3>Background</h3><div>Recent improvements in the HIV care cascade have reduced HIV incidence in high- and middle-income countries, yet late HIV diagnosis remains a critical issue. This study examines the impact of a two-hour training session on HIV testing and diagnosis rates in primary care centers in Madrid, Spain.</div></div><div><h3>Methods</h3><div>In 2017, we conducted a non-mandatory, two-hour training session on updated HIV and HCV guidelines for primary care providers in 20 centers within the Ramón y Cajal Hospital area. We compared yearly HIV testing rates and late diagnosis rates in the five years before and after the intervention. We used data from Ramón y Cajal Hospital Microbiology Department's electronic records and the CoRIS cohort, including demographic and clinical information.</div></div><div><h3>Results</h3><div>Of the 630 target primary care providers, 454 (72%) attended the sessions. HIV testing rates increased from 1780 to 2155 tests per 100,000 inhabitants (<em>p</em> <!-->&lt;<!--> <!-->0.0001) post-intervention, with a stable rate of positive tests. Late diagnosis rates in our area decreased from 58.9% to 48.7%, while rates in the rest of Madrid and Spain increased (AOR 1.22, <em>p</em> <!-->&lt;<!--> <!-->0.001). The intervention area showed a significant reduction in advanced HIV disease (AOR 0.66, <em>p</em> <!-->=<!--> <!-->0.095), contrasting with the upward trend in other regions.</div></div><div><h3>Conclusion</h3><div>A simple two-hour training session for primary care providers effectively increased HIV testing rates and reduced late diagnoses in our health area compared to national trends. Implementing similar strategies on a broader scale could help mitigate the rising rates of late HIV diagnosis and improve overall community health outcomes.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 645-651"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycolicibacterium iranicum en un paciente con bronquiectasias: importancia clínica y dificultades diagnósticas 支气管扩张患者中的伊朗分枝杆菌:临床意义和诊断困难
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.06.014
Diego González Polo, David Vázquez Gómez, Nieves Gutiérrez Zufiaurre
{"title":"Mycolicibacterium iranicum en un paciente con bronquiectasias: importancia clínica y dificultades diagnósticas","authors":"Diego González Polo,&nbsp;David Vázquez Gómez,&nbsp;Nieves Gutiérrez Zufiaurre","doi":"10.1016/j.eimc.2025.06.014","DOIUrl":"10.1016/j.eimc.2025.06.014","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 717-718"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacto de la implementación de MALDI-TOF y programas PROA en la optimización de la antibioterapia en bacteriemias por Staphylococcus aureus 实施MALDI-TOF和PROA项目对金黄色葡萄球菌细菌抗生素治疗优化的影响
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.06.005
Sara Vela-Bernal , Carlos Bea-Serrano , Ana Isabel de Gracia-Leon , Andreu Belmonte-Domingo , Carolina Pinto-Pla , Ana Ferrer-Ribera , Andrea de Castro-Oliver , Ignacio Torres , Javier Colomina , María Rosa Oltra-Sempere

Introduction

Rapid pathogen identification is key in the management of bloodstream infections. Antimicrobial stewardship programs (ASPs) have been shown to reduce resistance, adverse effects, and healthcare costs. MALDI-TOF MS enables fast and accurate microbial identification. This study evaluates the impact of its implementation on antibiotic therapy adequacy and mortality in Staphylococcus aureus bacteremia.

Methods

A quasi-experimental pre-post study was conducted at a university hospital, covering two periods: June 2015/April 2017 (pre) and June 2021/April 2023 (post). The impact of MALDI-TOF on antibiotic adequacy and mortality was analyzed.

Results

A total of 176 episodes were included (85 pre, 91 post). No significant epidemiological differences were observed between groups, although higher rates of sepsis and septic shock were noted in the post phase. MALDI-TOF was associated with improved antibiotic adjustment (3.51 vs. 1.75 days; P<.001). A non-significant trend toward lower early mortality was observed in the post-intervention group (P=.06). Mortality was associated with higher comorbidity (Charlson index), sepsis/septic shock, and MRSA bacteremia.

Conclusion

The implementation of MALDI-TOF, in conjunction with a multidisciplinary ASP, enhances early adjustment of empirical antibiotic therapy and may be associated with reduced early mortality in Staphylococcus aureus bacteremia. Incorporating rapid diagnostics, especially for MRSA detection, is a key strategy to improve clinical outcomes.
快速病原体鉴定是管理血液感染的关键。抗菌药物管理计划(asp)已被证明可以减少耐药性、不良反应和医疗保健费用。MALDI-TOF质谱能够快速准确地进行微生物鉴定。本研究评估其实施对金黄色葡萄球菌菌血症的抗生素治疗充分性和死亡率的影响。方法2015年6月/ 2017年4月(前期)和2021年6月/ 2023年4月(后期)在某大学附属医院进行准实验性的前后研究。分析MALDI-TOF对抗生素充分性和死亡率的影响。结果共收录176期,其中术前85期,术后91期。各组之间没有明显的流行病学差异,尽管在后期发现较高的败血症和感染性休克发生率。MALDI-TOF与改善抗生素调整相关(3.51天vs. 1.75天;P< 0.001)。干预后组早期死亡率降低的趋势不显著(P=.06)。死亡率与较高的合并症(Charlson指数)、败血症/感染性休克和MRSA菌血症相关。结论MALDI-TOF的实施,结合多学科ASP,加强了经验性抗生素治疗的早期调整,并可能与降低金黄色葡萄球菌菌血症的早期死亡率有关。结合快速诊断,特别是MRSA检测,是改善临床结果的关键策略。
{"title":"Impacto de la implementación de MALDI-TOF y programas PROA en la optimización de la antibioterapia en bacteriemias por Staphylococcus aureus","authors":"Sara Vela-Bernal ,&nbsp;Carlos Bea-Serrano ,&nbsp;Ana Isabel de Gracia-Leon ,&nbsp;Andreu Belmonte-Domingo ,&nbsp;Carolina Pinto-Pla ,&nbsp;Ana Ferrer-Ribera ,&nbsp;Andrea de Castro-Oliver ,&nbsp;Ignacio Torres ,&nbsp;Javier Colomina ,&nbsp;María Rosa Oltra-Sempere","doi":"10.1016/j.eimc.2025.06.005","DOIUrl":"10.1016/j.eimc.2025.06.005","url":null,"abstract":"<div><h3>Introduction</h3><div>Rapid pathogen identification is key in the management of bloodstream infections. Antimicrobial stewardship programs (ASPs) have been shown to reduce resistance, adverse effects, and healthcare costs. MALDI-TOF MS enables fast and accurate microbial identification. This study evaluates the impact of its implementation on antibiotic therapy adequacy and mortality in <em>Staphylococcus aureus</em> bacteremia.</div></div><div><h3>Methods</h3><div>A quasi-experimental pre-post study was conducted at a university hospital, covering two periods: June 2015/April 2017 (pre) and June 2021/April 2023 (post). The impact of MALDI-TOF on antibiotic adequacy and mortality was analyzed<strong>.</strong></div></div><div><h3>Results</h3><div>A total of 176 episodes were included (85 pre, 91 post). No significant epidemiological differences were observed between groups, although higher rates of sepsis and septic shock were noted in the post phase. MALDI-TOF was associated with improved antibiotic adjustment (3.51 vs. 1.75 days; <em>P</em>&lt;.001). A non-significant trend toward lower early mortality was observed in the post-intervention group (<em>P</em>=.06). Mortality was associated with higher comorbidity (Charlson index), sepsis/septic shock, and MRSA bacteremia.</div></div><div><h3>Conclusion</h3><div>The implementation of MALDI-TOF, in conjunction with a multidisciplinary ASP, enhances early adjustment of empirical antibiotic therapy and may be associated with reduced early mortality in <em>Staphylococcus aureus</em> bacteremia. Incorporating rapid diagnostics, especially for MRSA detection, is a key strategy to improve clinical outcomes.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 674-681"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manejo de esofagitis por citomegalovirus refractaria en un paciente con linfoma e inmunosupresión severa: foscarnet versus maribavir 在严重免疫抑制的淋巴瘤患者中,难以控制的巨细胞病毒引起的食管炎:foscarnet vs . maribavir
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.06.019
María Ángeles Asencio Egea , José María López-Pintor Huertas , Martín Cabero Becerra , Javier Sánchez López
{"title":"Manejo de esofagitis por citomegalovirus refractaria en un paciente con linfoma e inmunosupresión severa: foscarnet versus maribavir","authors":"María Ángeles Asencio Egea ,&nbsp;José María López-Pintor Huertas ,&nbsp;Martín Cabero Becerra ,&nbsp;Javier Sánchez López","doi":"10.1016/j.eimc.2025.06.019","DOIUrl":"10.1016/j.eimc.2025.06.019","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 718-719"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enfermedad diseminada grave en paciente gestante 孕妇的严重弥漫性疾病
IF 2.5 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2025-12-01 DOI: 10.1016/j.eimc.2025.05.009
Álvaro Liesa-Tordera , María Cano Navarro , Elisa Ibáñez-Martínez , Rafael Garcés-González
{"title":"Enfermedad diseminada grave en paciente gestante","authors":"Álvaro Liesa-Tordera ,&nbsp;María Cano Navarro ,&nbsp;Elisa Ibáñez-Martínez ,&nbsp;Rafael Garcés-González","doi":"10.1016/j.eimc.2025.05.009","DOIUrl":"10.1016/j.eimc.2025.05.009","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 10","pages":"Pages 714-716"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Enfermedades infecciosas y microbiologia clinica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1